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Abstract
Advances in chemistry and massively parallel detection underlie DNA sequencing platforms that
are poised for application in personalized medicine. In stark contrast, systematic generation of
protein-level data lags well-behind genomics in virtually every aspect: depth of coverage,
throughput, ease of sample preparation, and experimental time. Here, to bridge this gap, we
develop an approach based on simple detergent lysis and single-enzyme digest, extreme,
orthogonal separation of peptides, and true nanoflow LC-MS/MS that provides high peak capacity
and ionization efficiency. This automated, deep efficient peptide sequencing and quantification
(DEEP SEQ) mass spectrometry platform provides genome-scale proteome coverage equivalent to
RNA-seq ribosomal profiling and accurate quantification for multiplexed isotope labels. In a
model of the embryonic to epiblast transition in murine stem cells, we unambiguously quantify
11,352 gene products that span 70% of Swiss-Prot and capture protein regulation across the full
detectable range of high-throughput gene expression and protein translation.
Keywords
Quantitative proteomics; mass spectrometry; LC-MS; MS/MS; gene expression; microarray;
protein translation; ribosomal profiling; pluripotency; embryonic stem cells
The field of DNA and RNA sequencing has progressed at a remarkable rate since release of
the initial human genome draft sequences1, 2. Genotype-phenotype association studies
continue to elucidate large genomic regions that are amplified, deleted, or otherwise altered
in the context of human disease, although identification of specific causal gene elements has
proven to be a significant challenge3. Despite these and other successes4, primary DNA
sequence data does not capture downstream regulatory information for protein translation,
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tdegradation, and post-translational modification status5, 6, 7. These data are critical
components of studies designed to quantitatively monitor biological response to perturbation
or build predictive models of cellular physiology8. As a result, there remains a clear and
unmet need for methodologies that can provide systematic and scalable sequence
characterization of proteins as an important functional complement to DNA and RNA data.
The wide dynamic range of protein expression and vast array of post-translational
modifications, coupled with the lack of an analyte amplification strategy analogous to PCR,
presents tremendous challenges for genome-wide protein characterization, particularly for
signal transduction and other key regulatory factors that are often present in low abundance.
As a result, the majority of shotgun sequencing approaches frequently rely on low
throughput pre-fractionation (e.g., prior to LC-MS/MS analysis) of subcellular
compartments or intact proteins to improve dynamic range. While these techniques are
subject to continued improvements, they have not yet achieved genome-scale protein
identification and quantification. Moreover in many cases the labor-intensive nature of pre-
fractionation protocols hinders widespread adoption and standardization.
In this work we forgo cellular- or protein-level pre-fractionation altogether and instead rely
on direct detergent-based protein solubilization, followed by single-enzyme trypsin digest
and extensive, fully automated temporal separation of peptides through multiple
physicochemically orthogonal stages: high-pH reversed phase (RP) and strong anion
exchange (SAX) dimensions coupled in series and directly with a narrow-bore, extended
length (25 μ m × 100 cm) low-pH RP analytical column operated in a true nanoflow regime.
The latter chromatographic stage provides high peak capacity separation in a third
orthogonal dimension, along with increased electrospray ionization efficiency for improved
detection. The figures of merit for these individual components combine to yield an
automated deep efficient peptide sequencing and quantification (DEEP SEQ) mass
spectrometry platform that provides unprecedented separation capacity, rapid sequencing
speed, and quantification of proteins across the entire range of mammalian gene expression
and protein translation. We utilized multiplexed stable isotope labels in the context of a
model designed to profile early perturbations in the naïve, self-renewing ground state of
murine embryonic stem cells to quantify 211,535 unique peptide sequences that mapped
unambiguously to 11,352 gene products. These results span ∼ 70% of the highly curated
Swiss-Prot database, capture a vast majority of known pluripotent factors, and provide a
depth and scale of proteome coverage commensurate with genome-wide analysis of protein
translation by RNA-seq ribosomal profiling9.
Results
Peptide quantification by DEEP SEQ mass spectrometry
Multiplexed isotope labels have emerged as an enabling technology to increase the
throughput of quantitative proteomic studies and provide increased flexibility with respect to
experimental variables (time course, dose response, etc.)10. As these reagents have enjoyed
wider use, it has become apparent that quantification accuracy degrades significantly as the
complexity of target analyte mixtures increases. Simultaneous fragmentation of precursors
that overlap in m/z leads to a compression of discrete peptide ratios towards the mean of all
measured values11, 12, 13. We reasoned that the extreme temporal separation provided on our
protein deep sequencing platform would mitigate deleterious ratio compression effects. To
explore this hypothesis we created a mixed-species quantification model12, 13 in which the
contaminant peptides were present at a mass ratio of ∼ 6- and ∼ 32-fold greater as compared
to the target species, respectively (Fig. 1a). We acquired data at a depth of 20 DEEP SEQ
fractions (Methods) with an LTQ-Orbitrap XL and used multiplierz14, 15 to compile and
analyze extracted ion chromatograms for all detected peptides. We observed an average
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tchromatographic peak width measured at half-height of 27.8 seconds (Fig. 1b), with over
97% of all detected peptides spanning no more than two adjacent fractions (Fig. 1c),
yielding an empirical peak capacity16 of ∼ 1.3E4. Importantly, projection of peptide
sequence identifications as a function of first dimension organic and second dimension salt
concentrations (Fig. 1d) revealed that peptides were distributed throughout the entire
separation space, confirming that our platform provided orthogonal and extensive peptide
separation in these experiments. We next plotted iTRAQ ratios for species-specific peptides
and compared these to ratios observed in a conventional, single-dimension LC-MS/MS
analysis of the same sample mixture. The median ratio for the mixed-species channels
(116:114) in the standard LC-MS/MS analysis was compressed by some 40% as compared
to the single-species ratios (117:115); however, the equivalent analysis with DEEP SEQ
mass spectrometry revealed a relative ratio compression of only 8% (Fig. 1e and
Supplementary Data 1). Inspection of individual peptide spectra (Fig. 1f) reveals the marked
improvement in quantification data provided by our DEEP SEQ platform.
Genome-wide protein quantification comparable to ribo-seq
To further explore the performance of our deep protein sequencing platform we sought to
quantify changes in mESC protein expression resulting from withdrawal of leukemia
inhibitory factor (LIF), a cytokine required to maintain self-renewal in these cells. After
iTRAQ labeling we acquired MS/MS data at a depth of 20 DEEP SEQ fractions (Methods)
on a Triple TOF 5600 mass spectrometer (Fig. 2a). A single experiment which required
approximately 1 day for sample preparation and another 8 days for data acquisition yielded
nearly 2 million MS/MS spectra and 0.6 million peptide spectral matches (PSMs) based on a
search against the Uniprot database which is composed of Swiss-Prot (16,502 mouse genes)
plus Trembl (9,769 mouse genes) and contains 26,271 mouse genes in total. These PSMs
corresponded to180,867 peptides (≤1%FDR, including chemical modifications). Following
the convention described by Qeli et al.17 we mapped the set of 128,513 non-redundant
peptide sequences into the genome as follows: First, 107,722 peptides were uniquely
assignable to 9,818 gene IDs; we refer to these as “Class I” peptides and genes, respectively
(Fig. 2b). Of the remaining 20,791 peptides, 2,819 sequences mapped to at least two of
another 1,737 gene IDs (“Class II” peptides and genes, respectively, Supplementary Data 2);
importantly Class II peptides do not map to Class I genes. The remaining 17,972 peptides
(“Class III” peptides) map to multiple genes, including one or more Class I genes. Class III
peptides are included in the count of total peptide detections but are not otherwise
considered for purposes of protein identification. Cumulatively across three biological
replicate experiments, comprising 24 days of data acquisition, we obtained ∼ 5.9 million
MS/MS spectra, ∼ 1.8 million PSMs, and identified 211,535 non-redundant peptide
sequences (178,167 Class I, 3,496 Class II, and 29,872 Class III peptides, respectively). This
peptide set encompassed 13,075 and 2,824 Class I and II genes, respectively (Fig. 2c), with
the former (Class I genes) spanning 50% of UniProt and nearly 70% of the manually
curated, non-redundant Swiss-Prot mouse database (Fig. 2d,e).
Two recent reports18, 19 that sought to analyze global protein expression in mESC utilized
pre-fractionation of sub-cellular compartments, proteins, or peptides (or some combination)
prior to LC-MS/MS. We took the union of published data from these studies and found that
results from our DEEP SEQ platform encompass ∼ 73% and ≥95% of the reported peptide
and gene IDs, respectively, while adding a significant quantity of new sequence information
(Fig. 3a and Supplementary Data 3). Although the fractionation approaches, mass
spectrometry instrumentation, and database search engines varied across these three studies
we observed very similar physicochemical properties for peptides identified in each data set
(Fig. 3b,c). To explore the dynamic range of proteins identified across these data we next
overlaid Class I and II genes derived from each peptide set with mRNA expression data for
Zhou et al. Page 3
Nat Commun. Author manuscript; available in PMC 2014 January 17.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tmESC20 (Fig. 3d and Supplementary Data 4). Class I genes identified in our data spanned
the full dynamic range of gene expression, with new Class I peptides identified through
additional replicate experiments generally mapping to genes expressed at lower levels.
Moreover, peptides identified by the two previous studies18, 19 were biased to high-
expression genes as compared to those in our data. Strikingly the addition of Class II genes
from our DEEP SEQ analysis improved overall proteome coverage only incrementally as
compared to the set of Class I genes alone, with a small bias towards low-expression genes.
Given the limitations of microarray data as a surrogate for protein expression, we next
sought to compare our proteomic data with that from ribosomal profiling by RNA-seq, a
technique that monitors protein translation on a genome-wide scale21. In a recent ribosomal
profiling study, Ingolia et al.9 measured translation of 12,674 transcripts from 19,022 protein
coding genes in mESC. Our set of Class I and II genes spanned an equivalent fraction of the
total gene space (63%) and encompassed 81% of all translation events represented in the
ribosomal profiling data (Fig 3e and Supplementary Data 5). Again we observed that our
deep sequencing data spanned the entire dynamic range of protein translation as represented
by ribosomal profiling, including significant coverage (∼ 42%) of low-frequency translation
events (Fig. 3f). As was observed with the comparison to gene expression by microarray,
our data exhibited significantly higher coverage of low-expression genes as compared to that
from previous studies of the mESC proteome18, 19, while inclusion of DEEP SEQ Class II
genes provided only a negligible improvement in proteome coverage. The latter observation
is particularly notable given that Class II genes are defined by shared peptides; as a result
the data for these gene products is ambiguous with respect to identification and
quantification. For these reasons we focused the remainder of our analyses exclusively on
Class I genes. Collectively these results suggest that our protein deep sequencing platform
provides accurate quantitative data for multiplexed stable isotope reagents while
simultaneously maximizing the discovery potential in the analysis of complex mammalian
proteomes. In fact, using very stringent criteria for unambiguous protein identification
(Class I peptides) our DEEP SEQ mass spectrometry approach provides data that span the
full dynamic range of mammalian protein expression.
Functional proteome coverage by DEEP SEQ mass spectrometry
Regulatory proteins such as transcription factors, kinases and other signal transduction
factors are often underrepresented in mass spectrometry-based whole-proteome studies.
Hence we next sought to evaluate the coverage of functional protein classes provided by our
DEEP SEQ platform. We found that the set of Class I peptides mapped unambiguously to
≥40% of genes across Gene Ontology (GO) functional categories, regardless of the evidence
filter used (Fig. 4a). We also observed that the coverage varied across categories, from
nearly 100% for genes encoding ribosome and proteasome proteins to approximately 20%
for transmembrane receptors; the same trend was observed for data derived from ribosomal
profiling, suggestive of a general correlation between coverage and protein abundance (Fig
4b). This hypothesis was further corroborated by mapping functional protein classes to gene
expression in mESC (Fig. 4c). Consistent with these data we found that replicate
experiments tended to augment representation of proteins encoded by genes expressed at
low levels. Overall, our set of stringently defined Class I genes spanned 52% of the
functional proteome, on par with coverage provided by ribosomal profiling (56% coverage);
importantly, our DEEP SEQ mass spectrometry data captured ≥70% of key regulatory
protein classes, including kinases, phosphatases, and transcription factors.
Quantification of LIF-dependent functional proteome in mESC
To explore the functional proteome characteristic of mESC, we next compiled two reference
sets of pluripotent factors derived from genetic depletion screens22, 23 and proteins
biochemically associated with the master regulatory transcription factors Oct4 and
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tNanog24, 25, 26 (Supplementary Data 6). The set of Class I genes from our biological
triplicate analysis encompassed ∼ 81% (Fig. 5a) and ∼ 90% (Fig. 5b) of these reference gene
sets, respectively, suggesting that our DEEP SEQ mass spectrometry platform can capture
regulatory events associated with key mediators of pluripotency in mESC. A plot of
quantitative data (Fig. 5c) revealed numerous proteins (Table 1) whose expression level
reproducibly increased or decreased in response to LIF withdrawal (Supplementary Data 7).
Query of these proteins against the functional and biochemical reference sets demonstrated
an enrichment (Fishers exact test, Pval = 2.1E-5) for pluripotent factors (Fig. 5d).
Biochemical validation (Fig. 5e) of LIF-mediated expression for a sub-set of proteins
confirms the power of DEEP SEQ mass spectrometry to provide accurate quantification for
multiplexed isobaric labels in the context of genome-wide proteome profiling.
Discussion
Continued advances in our understanding of genome variation2, gene expression27, 28, and
translation9, driven in-part by the advent of next-generation DNA/RNA sequencing
technologies3, has effectively re-kindled interest in experiments designed to maximize
discovery potential and simultaneously quantify known genomic or other biomolecular
events. Establishing a parallel trajectory for this paradigm in proteomics is complicated by
the broad range of protein abundance, diverse repertoire and stoichiometry of post-
translational modifications, as well as the stochastic nature of discovery-driven or shotgun
MS/MS acquisition methods. In fact today, nearly two decades after Marc Wilkens first
coined the term, “proteome”29, the dynamic range of protein expression in mammalian
systems has represented an insurmountable hurdle for genome-wide proteome
quantification. Despite these obstacles, the functional content of protein-level data
represents an important complement to genomic-based studies, and hence there remains
significant motivation to develop scalable platforms for proteomic analyses.
In order to achieve true, genome-scale sequence coverage along with high-fidelity protein
quantification, we sought to significantly improve the analytical figures of merit for each
component of our DEEP SEQ mass spectrometry platform. First the use of
physicochemically orthogonal high-pH reversed phase and strong anion exchange separation
stages16, 30 coupled with a narrow-bore (25 μ m I.D.), extended length (100 cm) low-pH
analytical column31 provides extreme temporal separation of peptides with an empirical
peak capacity of ∼ 1.3E4. Our experience with online multidimensional separations16, 30
indicates that further optimization of first and second dimension eluent concentrations can
yield an improved distribution of peptides across each separation dimension, ultimately
providing deeper proteome coverage beyond the ∼ 70% achieved herein. Second, the final
dimension column geometry maintains the integrity of chromatographic separation at ultra-
low effluent flow rates (∼ 5nL/min), thus maximizing electrospray ionization
efficiency32, 33. Third, all separation stages in the DEEP SEQ configuration are
implemented in microcapillary format and coupled in series, with the final dimension
interfaced directly to the mass spectrometer, providing for fully automated operation, along
with efficient capture and transfer of peptides across all separation stages.
Based on a stringent peptide-to-gene I.D. criterion, our DEEP SEQ mass spectrometry
analysis of mESC provided quantitative expression data for 11,352 out of 16,502 genes in
SwissProt (∼ 69%, Fig. 2e), a depth of coverage equivalent to a recent study in which RNA-
seq ribosomal profiling was used to measure translation of 12,674 out of 19,022 (∼ 66%)
protein coding genes contained in the UCSC mouse database9. Importantly our data provide
significant coverage (∼ 70-85%) for key regulatory protein families, including kinases,
ubiquitin ligases, and transcription factors (Fig. 4b). In fact, proteins quantified on our deep
sequencing platform span the full dynamic range of corresponding gene expression and
Zhou et al. Page 5
Nat Commun. Author manuscript; available in PMC 2014 January 17.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tprotein translation profiles (Fig. 3d-f). Not surprisingly, improvements in proteome coverage
across triplicate experiments were most pronounced for low-expression protein families
(Fig. 4c).
The absence of protein amplification strategies analogous to PCR, combined with the
limited improvements in dynamic range offered by each generation of mass spectrometry
hardware, places a disproportionate burden on separation techniques to achieve robust
detection of low-abundance proteins. Despite numerous methodological studies, the choice
of separation strategies that will provide the best combination of sample yield, experiment
time, and ultimately, proteome coverage is unresolved. Our results refute the notion that
analysis of tryptic peptides alone is insufficient to characterize proteins across a wide
dynamic range of abundance. In practice, DEEP SEQ mass spectrometry achieves
significantly higher proteome coverage (Fig. 3a) from only a fraction (<5%) of the input
required by techniques that rely on protein- or cellular-level pre-fractionation18, 19. In fact,
while chromatographic and sub-cellular fractionation are slow and low-throughput
compared to chemical amplification, the time required for our DEEP SEQ analysis (25 days
for biological triplicates, including sample preparation) is not dramatically different from
other recent attempts at deep protein sequencing by mass spectrometry (for example, 21
days for a study that relied on the use of protein level fractionation and multiple enzymes34),
or for that matter genome-wide RNA-seq ribosomal profiling (9-12 days as described in a
recent reveiw35). Finally it is worth noting that our DEEP SEQ approach provides the
serendipitous benefit of a robust and streamlined sample preparation protocol. Simple
detergent solubilization, single enzyme digestion, peptide desalting, and iTRAQ labeling is
somewhat reminiscent of the commoditized kits used in conjunction with next-generation
DNA/RNA sequencing.
The quality of peptide fractionation provided by our deep protein sequencing platform is
also evident in the analysis of a mixed-species iTRAQ quantification model (Fig. 1a). Even
with contaminant species present in >30-fold excess relative to the target peptides, our
DEEP SEQ mass spectrometry platform provided sufficient separation peak capacity to
yield accurate iTRAQ ratios (Fig. 1e). These data are important in light of discrepancies
reported between the throughput advantages afforded by multiplexed reagents and the well-
documented limitations encountered when using these labels to quantify proteins in complex
mixtures11, 12, 13, 36. In fact, results from three of these studies12, 13, 36 demonstrated
unequivocally that two dimensions of peptide fractionation are insufficient to abrogate
suppression of multiplexed ratios for analysis of samples intended to represent complex
proteomes. Importantly, DEEP SEQ mass spectrometry provides a platform to reconcile
these juxtaposed observations and fully leverage the advantages of isobaric reagents in
studies designed to quantify proteome response to perturbation on a genome-wide scale.
Moreover, recent reports37, 38 suggest the possibility of significant increases in the degree of
multiplexing for these stable isotope reagents. These advances, along with improvements in
mass spectrometry instrumentation39, 40 in addition to new chromatographic41, 42, 43 and
electrophoretic44, 45, 46 separation platforms, will yield a concomitant increase in the
throughput of DEEP SEQ mass spectrometry analysis.
Finally, our data provide insight into the transition of mESC from a naïve ground state,
similar to that observed in the embryo inner cell mass prior to implantation, to a post-
implantation epiblast-like stage (mEpiSC) that is poised for directed differentiation47. LIF is
a critical cytokine that supports self-renewal in mESC through the Jak-Stat and Pi3k-Akt
signaling axes, while opposing pathways, including Wnt-Gsk3β  and Mek-Erk, mediate
transcription programs that degrade pluripotent potential48. How these and other exogenous
stimuli coordinately influence the core pluripotent genes (Oct4 and Sox2) and other
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tperipheral factors to enforce the transcriptional ground state or mediate lineage commitment
is not yet fully resolved.
Strikingly we detect regulated protein expression for downstream targets linked to each of
these discrete pathways (Klf4, Klf549, Lef150, Esrrb, Tcfcp2l151 and Tbx348). Proteins
having roles in other developmental contexts (Otx252, Pou3f1/Oct653, and CD954, 55) along
with epigenetic factors (Dnmt3a/b) that are critical for high-fidelity gene expression56, were
also regulated in a LIF-dependent manner. In addition to these studies that targeted specific
genes or pathways, our DEEP SEQ analysis also quantified the majority of pluripotent
factors previously defined by high-throughput functional genetic22, 23 and biochemical
interaction24, 25, 26 assays (Fig. 5a,b). Indeed, we reproducibly observed regulated
expression for 50 proteins (Table 1) and found that these were enriched for pluripotent and
developmental genes (Fig. 5d). Importantly, this set of putative LIF-dependent protein
targets spans the full dynamic range of gene expression and protein translation in mESC
(Fig. 5f,g). Thus, though results presented herein represent a single time point in the LIF-
mediated transition between naïve and primed epiblast states, the depth and scale of these
data provide compelling evidence that our DEEP SEQ mass spectrometry platform can
capture the vast majority of the mESC functional proteome in the context of more complex
experiments57, 58 designed to decipher individual contributions of the above pathways to
self-renewal and lineage commitment. More generally our DEEP SEQ mass spectrometry
platform represents a powerful and scalable approach for genome-wide profiling of protein
expression and post-translational modification status in mammalian systems.
Methods
Cell culture
Yeast cells were grown and processed under conditions similar to those described
previously30. S. cerevisiae, strain S288C, BY4741 (ATCC 201388, MATa his3Δ 1
leu2Δ 0met15Δ 0 ura3Δ 0) was grown in yeast extract peptone dextrose (YEPD) liquid
medium to log phase, OD600 ≈0.7 at 30°C. Cells were lysed by the addition of boiling SDS
(50mM Tris-HCl, pH 7.5, 7.5% SDS, 5% glycerol, 50mM DTT, 5mM EDTA), followed by
centrifugation, with the supernatant stored at −80 °C.
Mouse embryonic stem cell (mESC) line J1 was generously provided by Dr. Stuart Orkin
(Dana-Farber Cancer Institute and Children's Hospital, Boston, MA). Initially, 10cm
Nunclon tissue culture dishes (ThermoFisher Scientific, Waltham, MA) were coated with
0.1% Gelatin (EMD Millipore, Billerica, MA) at room temperature for 30 minutes. Gelatin
was aspirated and J1 mESC were plated at a density of ∼ 6 × 104/cm2 in Dulbecco's
modified Eagle's medium with high glucose supplemented with L-glutamine (Gibco Life
Technologies, Carlsbad, CA), 15% embryonic stem cell validated FCS (Stem Cell
Technologies, Vancouver BC, Canada), 2-mercaptoethanol, nucleosides (EMD Millipore,
Billerica, MA), nonessential amino acids (Gibco Life Technologies, Carlsbad, CA), and 10
ng/mL murine LIF6 (EMD Millipore, Billerica, MA). Perturbation experiments were
performed by establishing J1 mESC under the above conditions and then removing LIF6 for
48 hours. At the time of harvest, plates were washed with cold PBS to remove serum
proteins and adherent cells were lysed by the addition of a boiling SDS (50mM Tris-HCl,
pH 7.5, 7.5% SDS, 5% glycerol, 50mM DTT, 5mM EDTA). Lysed cells were centrifuged
and the supernatant extract was stored at −80 °C.
Sample preparation for DEEP SEQ analysis
Proteins were precipitated by adding six volumes of cold (−20°C) acetone and resolubilized
in digestion buffer containing 8 M urea and 0.1 M NH4HCO3. Total protein levels were
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tmeasured by BCA. Dithiothreitol (DTT) was added to a final concentration of 10 mM and
incubated for 30 minutes at 60 °C, followed by addition of methyl methanethiosulfonate
(MMTS) (ThermoFisher Scientific, Waltham, MA) to 20 mM. After 30 min. incubation in
the dark at room temperature, excess MMTS was quenched by addition of DTT to a final
concentration of 20 mM. Reduced and alkylated proteins were diluted in 0.1M ammonium
bicarbonate, followed by addition of trypsin, with overnight digestion 37 °C and end-over-
end rotation. Digested sample solutions were loaded onto SepPak C18 reverse phase
cartridges (Waters Corp., Milford, MA) to remove urea and other salts. Eluted peptides
(45% acetonitrile in water with 0.1% trifluoroacetic acid) were lyophilized by vacuum
centrifugation.
Peptides were labeled with 4-plex iTRAQ reagents (AB Sciex, Framingham, MA). Two
aliquots of 0.2 μ g yeast peptides were labeled with 114 and 115. Separately, two other
aliquots of 1.0 μ g yeast peptides were labeled with 116 and 117. In addition, two aliquots of
6.3 μ g peptides from mESC were labeled with 114 and 116. For the mESC perturbation
experiment, peptides from the cells incubated without LIF were labeled as technical
replicates with iTRAQ116 and 117, while peptides from the cells incubated with LIF were
labeled as technical replicates with iTRAQ 114 and 115. For each reaction, peptides were
resuspended in 500mM triethylammonium bicarbonate and mixed with the appropriate
iTRAQ reagent in ethanol. Labeling was allowed to proceed at room temperature for one
hour; samples were then combined and dried by vacuum centrifugation. Fresh aliquots of
mESC were processed as described above to provide biological triplicates.
DEEP SEQ multi-dimension separation
Three dimension peptide separation was performed on a modified Waters (Milford, MA)
NanoAcquity UHPLC system with binary and isocratic pumps, along with an autosampler
and additional 6-port, 2-position valve (Valco, Austin, TX). The 1st dimension reversed
phase (RP) column consisted of a 200 μ m I.D. capillary packed with 20 cm of 5 μ m dia.
XBridge C18 resin (Waters Corp., Milford, MA). An anion exchange column (200 μ m I.D.
× 20 cm) was packed with 5μ m dia. SAX resin (Sepax Technologies, Neward, DE) and
connected to the outlet of the 1st dimension RP column. The 3rd dimension consisted of
reversed phase pre- (100 μ m I.D. ×4 cm of 10μ m dia. POROS 10R2 resin) and analytical
(25μ m I.D. ×100 cm of 5 μ m dia. Monitor C18 [Column Engineering, Ontario, CA], with
integrated 1 μ m dia. emitter tip) columns configured in a vented geometry59, 60. The
autosampler picked up and delivered either peptide samples or 1st (acetonitrile in 20mM
ammonium formate, pH 10) and 2nd (KCl in 20 mM ammonium formate, pH 10) dimension
eluents at 2μ L/min. through the sample loop. Injection of each 1st or 2nd dimension eluent
constitutes a “DEEP SEQ fraction” (Supplementary Data 8). The binary pump delivered
0.1% formic acid at 8μ L/min. to dilute the organic content and acidify the 1st/2nddimension
effluent prior to the 3rd dimension pre-column, or provided for gradient elution (2-50% B in
580 minutes, A = 0.1% formic acid, B = acetonitrile with 0.1% formic acid) of peptides
from the 3rd dimension reversed phase columns for LC-MS/MS analysis at a flow rate of
∼ 5nL/min. A Digital PicoView electrospray source platform (New Objective, Woburn, MA)
was used on both the Orbitrap XL and 5600 Triple TOF mass spectrometers to automatically
position the emitter tip at the source inlet during LC-MS/MS acquisition or beneath a
gravity-driven drip station during injection of peptide samples or 1st/2nd dimension eluents.
DEEP SEQ sample capacity and experiment time
Based on our published and unpublished studies, we estimate that the total loading capacity
of our first dimension RP column (200 μ m I.D. × 20 cm) is currently ∼ 100 μ g. The DEEP
SEQ platform is easily tailored to a variety of sample types. Generally, first and second
dimension eluent concentrations in a range of 7 to 55% acetonitrile and 10 to 300 mM KCl
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trepresent the useful boundaries for peptide elution. Importantly, our experience to date
suggests that these conditions are robust with respect to biological input, obviating the need
to run repeated pilot experiments for every sample. Total time of analysis is another
important consideration when using multidimensional fractionation techniques. For
example, DEEP SEQ experiments performed at a depth of 20 fractions required 8 days for
data acquisition. System reliability is particularly important given that a single, DEEP SEQ
mass spectrometry analysis will typically require several days of continuous instrument
time. Importantly, all data presented herein were acquired using a single 25μ m I.D. ×100 cm
resolving column, demonstrating the robustness of our platform.
DEEP SEQ mass spectrometry data acquisition parameters
The LTQ-Orbitrap XL mass spectrometer (Thermo, Waltham, MA) was operated in data
dependent mode, such that the top 10 most abundant precursors in each MS scan were
subjected to MS/MS in both CAD and HCD mode (CAD in the linear trap, normalized
collision energy = 35%, precursor isolation width = 1.9 Da, intensity threshold for precursor
selection = 20,000 HCD in the orbitrap, normalized collision energy = 47%, precursor
isolation width = 1.0 Da, intensity threshold for precursor selection = 20,000). Dynamic
exclusion was enabled with a repeat count of 1 and exclusion duration set to 20 seconds.
Electrospray voltage was 2.2 kV. We enabled the Lock Mass feature and selected m/z =
445.120025 ([Si(CH3)2O]6) as the internal calibrant.
The 5600 Triple TOF (AB Sciex, Framingham, MA) was operated in information dependent
mode (IDA), with the top 50 precursors (charge state +2 to +5, >100 counts) in each MS
scan (800 ms, scan range 350-1500 m/z) subjected to MS/MS (minimum time 140 ms, scan
range 100-1400m/z). A dynamic exclusion window of 20 s was used with unit resolution for
precursor isolation. Electrospray voltage was 2.2 kV.
DEEP SEQ mass spectrometry data processing
Our API-based multiplierz software framework was used to extract and format MS/MS data
from the Orbitrap XL for subsequent search against the Uniprot mouse database
(downloaded on 11/02/2011) and a S. cerevisiae database (downloaded from http://
www.yeastgenome.org/01/06/2010). MS/MS data was searched using Protein Pilot V4.4
(AB Sciex, Framingham, MA) with the following parameters: instrument =“Orbi/FT MS
(sub-ppm), LTQ MS/MS” for data acquired with the Orbitrap XL, or “5600 TripleTOF” for
data acquired with the 5600 Triple TOF mass spectrometer. A fixed modification of +42
corresponding to MMTS of cysteine was also included. The sample type was set to “iTRAQ
4-plex (peptides labeling)”. All peptide spectral matches (PSM) from biotriplicate
acquisitions were combined for the FDR assessment. Only those peptides with scores at or
above a PSM FDR threshold of 1% were further considered. All peptides were mapped back
to the genome without consideration of splice isoforms from the same gene. Following the
procedure of Qeli et al.17, peptides passing the 1% FDR filter were classified as either
“unique” or “shared” based on whether they could be assigned to only one or more than one
gene, respectively. Class I genes were defined as those identified only by uniquely
assignable peptides. Class II genes were identified based on shared peptides that could not
be assigned to any Class I gene. The results reported herein are based on Class I and Class II
genes; no Class III genes were included in our analyses. Multiplierz scripts were used to
systematically extract XICs and calculate corresponding peak widths for all identified
peptides. To estimate the orthogonality of peptide fractionation, the number of unique
peptides identified in each third dimension LC-MS/MS run was represented as a circle of
proportional diameter and projected onto a 2D plot at the corresponding 1st dimension
acetonitrile (x-axis) and 2nd dimension salt (y-axis) concentrations used in the experiment.
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1.4.1, with each unique peptide sequence used as a separate data point.
In the mixed species quantification experiments the iTRAQ116/iTRAQ114 and iTRAQ117/
iTRAQ115 ratios were first normalized based on all spectra identified (final normalization
factor was 1.14). We used R scripts to create box-plots for all iTRAQ ratios. For the
quantitative analyses of mESC, we summed iTRAQ channels in each biological condition
(±LIF) for Class I peptides to generate a final ratio for each Class I gene. Across three
biological triplicate experiments a protein was considered to be regulated in expression
(Table 1) if the following criteria were met in two out of the three experiments: (i) the
iTRAQ intensities exceeded 200 counts and (ii) the Log2 iTRAQ ratio was ≥1 or ≤ −1.
Enrichment of pluripotent factors within the set of genes whose expression was reproducibly
regulated across biotriplicate experiments was estimated using a Fisher's exact test. A null
distribution and two-sided p-value were calculated based on code freely available at: (http://
research.microsoft.com/en-us/um/redmond/projects/MSCompBio).
Comparisons to mESC microarray and ribosomal profiling data
Comparison of DEEP SEQ mass spectrometry data to that from ribosome profiling for
mESC was performed as follows: The UCSC mouse genome database (mm9) (http://
hgdownload.soe.ucsc.edu/goldenPath/mm9/database/) was downloaded on 10/02/2012. We
aligned the peptides identified in triplicate DEEP SEQ mass spectrometry analyses against
sequences in the UCSC database. A similar alignment was performed for mESC ribosomal
profiling data previously reported9. In 1,034 cases we were unable to reconcile gene names
from the UCSC and UniProt databases; these genes were removed from further
consideration. Average gene expression levels across three wild type mESC lines (B21, J1
and R1) was calculated using published datasets (accession codes GSM338369,
GSM338371, GSM338373)20. We used the R/Bioconductor software environment to re-
normalize all microarray data based on the multi-array averaging method (RMA) and to re-
map all probe sequences to Entrez Gene IDs using a custom Chip Definition File (CDF)
from the Michigan Microarray Lab (version 13). The average mRNA expression level (in
Log2 space) between the three arrays was calculated and the Entrez Gene IDs were
converted to UniProt gene symbols. UniProt entries mapping to more than one Entrez Gene
ID were excluded. The final list contained 15,705 entries of (average Log2 expression value)
| (UniProt gene symbol) pairs.
Gene ontology and reference gene sets for pluripotency
Positive reference sets (PRS) of pluripotent genes were created from RNAi screening data
downloaded from two previous studies22, 23. Similarly, pluripotency reference genes based
on biochemical interactors of Nanog and Pou5f1 (Oct4) were created from three previous
studies24, 25, 26.
The Gene Ontology (GO) database was downloaded on 03/15/2012. The GO subcategories
were filtered based on different identifiers: Molecular function (GO:0003674), Biological
process (GO:0008150), Signaling (GO:0023052), Ribosome (GO:0005840), Proteasome
(GO:0000502), Protein folding (GO:0006457), Kinase (combination of GO:0004672 and
GO:0016301), Phosphatase (combination of GO:0016791 and GO:0004721), Ubiquitin
ligase (GO:0004842), Transcription factor (combination of GO:0006351 and GO:0008134),
Stem cell maintenance (GO:0019827), Chromatin remodeling (GO:0006338), Membrane
(GO:0016020), Cell adhesion (GO:0007155) and Transmembrane receptor (GO:0004888).
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tWestern Blotting
Protein lysates from ∼ 3 × 105 murine ESC (about 30μ g total protein) incubated with or
without LIF were separated on 4-12% Bis-Tris gels (Life Science) under reducing
conditions and transferred onto polyvinylidene difluoride membranes. The blot was stained
with antibodies against Lef1 (Cell Signaling Technology, 1:1000), Pou3f1 (Abcam, 1:1000),
Esrrb (Cell Signaling Technology, 1:1000), Otx2 (Abcam, 1:1000), Klf4 (Cell Signaling
Technology, 1:1000), Cd9 (Abcam, 1:1000), and Gapdh (Cell Signaling Technology,
1:6000). The bands were visualized by enhanced chemiluminescence (Thermo, SuperSignal
West Femto Chemiluminescent Substrate).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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tFigure 1. DEEP SEQ mass spectrometry provides extreme separation and accurate
quantification of iTRAQ labeled peptides
(a) A mixed-species iTRAQ quantification model consisting of tryptic target peptides from
yeast: 0.2 μ g (114), 0.2 μ g (115), 1.0μ g (116), and 1.0μ g (117), and contaminant peptides
from murine embryonic stem cells (mESC): 6.3 μ g (114) and 6.3 μ g (116). Contaminant
peptides are 6.3× and 31.5× more abundant in the iTRAQ 116 and 114 channels,
respectively, as compared to the yeast target peptides. (b) Histogram of extracted ion
chromatogram peak width for peptides identified in 20 fraction DEEP SEQ MS/MS analysis
of mixed-species model. (c) Analysis of peptide elution profiles demonstrates minimal
fraction-to-fraction overlap, with ∼ 97% of all identified peptides constrained within two
adjacent 1st/2nd dimension (high pH RP/SAX) fractions. (d) The number of identified
peptides represented as circles of proportional diameter and plotted as a function of 1st and
2nd dimension eluent concentration; low correlation coefficient for least-squares fit of these
data (R2 = 0.01) suggests orthogonal fractionation of peptides across high pH reversed phase
and strong anion exchange dimensions. (e) Log2 iTRAQ ratios of peptides identified in the
mixed-species model displayed in box-plot format for conventional single dimension LC-
MS/MS and DEEP SEQ analyses. The data include 272 yeast-specific peptides and 1570
mouse-specific peptides in 1D mode along with 2446 yeast-specific and 20461 mouse-
specific peptides identified the DEEP SEQ analysis. Boxes encompass the interquartile
range with respective median values indicated with stripes; whiskers represent 1.5× the
interquartile range with outliers shown as open circles. Non-transformed, median ratios are
listed at the top along with relative ratio compression for contaminated (116:114, blue + red)
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tversus non-contaminated (117:115, blue) iTRAQ ratios. Analysis of mESC contaminant
peptides alone (two right-most box plots) provides a positive control for iTRAQ ratios
measured in conventional LC-MS/MS and DEEP SEQ analyses, respectively. (f, g)
Representative MS/MS spectra for a tryptic peptide (EVGITAVHVK) acquired during (f)
typical shotgun LC-MS/MS and (g) DEEP SEQ mass spectrometry analyses. Low-mass m/z
region shows iTRAQ signals for each fragment ion spectrum along with measured ratios for
contaminated (116:114, blue + red) and non-contaminated (117:115, blue) channels.
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tFigure 2. DEEP SEQ mass spectrometry data spans 70% of protein-coding genes in murine
embryonic stem cells
(a) mESC were cultured in the absence of leukemia inhibitory factor (LIF) for 48 hours.
Proteins were solubilized and processed directly (e.g., no sub-cellular or protein-level
fractionation) for iTRAQ labeling (two replicates per condition), followed by DEEP SEQ
mass spectrometry analysis. (b) A single, 20-fraction DEEP SEQ mass spectrometry
analysis provided nearly 2 million MS/MS spectra, ∼ 610,000 peptide spectral matches
(PSMs, <1%FDR), and 180,867 peptides corresponding to 128,513 unique peptide
sequences. High-confidence (<1%FDR) peptide sequences were classified based on whether
they mapped uniquely to mouse gene I.D.s (Class I peptide, Class I gene) or were shared
across two or more mouse genes outside the set of Class I genes (Class II peptides, Class II
genes). These data required 8 days of continuous acquisition time and yielded 9,818 Class I
gene I.D.s. (blue). (c) Across biological triplicates, DEEP SEQ mass spectrometry analysis
identified 13,075 Class I genes derived from ∼ 5.9 million MS/MS spectra acquired over 24
days. These data spanned (d) 50% of all protein-coding genes in the Uni-Prot database
(26,271 entries). (e) The set of Class I peptides mapped unambiguously to nearly 70% of
protein-coding genes in the manually annotated, non-redundant Swiss-Prot database (11,352
out of 16,502 total entries).
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tFigure 3. Protein identification across thefull dynamic range of gene expression and protein
translation in mESC
(a) High-confidence peptides based on the union of published data from two previous mESC
proteomic studies18, 19 were mapped to Class I and II gene I.D.s as described (see Methods)
and compared with data from this study. High-confidence peptides identified in all three
studies exhibited similar physicochemical properties, including (b) molecular weight
distribution and (c) number of amino acids per peptide. Comparison of (d) Class I and II
gene I.D.s with normalized mRNA levels in mESC demonstrates that DEEP SEQ mass
spectrometry data spans the full range of gene expression. (e) The fraction of genes
represented in the UCSC mouse database (grey) captured by ribosomal profiling (yellow)
and DEEP SEQ mass spectrometry (red). The set of Class I and II genes identified herein
encompassed 81% of protein translation events as represented by RNA-seq ribosomal
profiling. (f) Overlay of ribosomal profiling data with that from DEEP SEQ mass
spectrometry analysis demonstrates that the set of Class I genes spans the full dynamic range
of protein translation in mESC.
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tFigure 4. DEEP SEQ mass spectrometry provides extensive coverage of the mammalian
functional proteome
(a) Relative coverage provided by DEEP SEQ mass spectrometry and ribosomal profiling as
a function of gene-ontology (GO) category and evidence filter. As defined by GO, “Manual
All” contains all curator-reviewed experimental and computational annotations while
“Manual Experiment” includes only curator-reviewed annotations derived from direct assay
(IDA), physical interaction (IPI), mutant phenotype (IMP), genetic interaction (IGI), and
expression pattern (IEP) evidence categories. (b) Relative coverage of GO protein families
for DEEP SEQ mass spectrometry and ribosomal profiling analyses. Protein membership in
each family is derived from the annotations within “Manual Experiment.” (c) Relative
mRNA expression level plotted in box-plot format (black and white, y-axis, right) as a
function of GO protein families. Boxes encompass the interquartile range with respective
median values indicated with stripes; whiskers represent 1.5× the interquartile range with
outliers shown as open circles.(blue, y-axis, left) Relative increase in GO protein family
representation across bio-triplicate DEEP SEQ mass spectrometry analyses for Class I
genes.
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tFigure 5. DEEP SEQ mass spectrometry provides genome-wide proteome quantification in
mESC subject to LIF withdrawal
The set of Class I gene I.D.s from bio-triplicate, 20-fraction DEEP SEQ mass spectrometry
experiments encompassed (a) ∼ 80% of murine pluripotent factors as defined by systematic
genetic depletion assays22, 23 and (b) ∼ 90% of the Nanog and Oct4 transcription factor
network as defined through analysis of biochemical interactions24, 25, 26. (c) Scatter plot of
iTRAQ log-intensity versus log-ratio for 13,075 class I gene I.D.s identified across bio-
triplicate, 20-fraction DEEP SEQ mass spectrometry experiments. Individual iTRAQ signals
for each high-confidence Class I peptide were summed across technical and biological
replicates; these aggregate ratios were then combined to provide protein-level ratios. (d)
Fisher's Exact Test confirms that the set of regulated proteins (Table 1) identified by DEEP
SEQ mass spectrometry analysis is enriched (two-sided Pval = 2E-5) for pluripotent factors
as defined by systematic loss-of-function and biochemical interaction assays. (e) Selected
pluripotent and developmental factors were probed by western blot in mESC at 24 and 48
hrs after withdrawal of LIF. Left-most column indicates molecular weight markers. Overlay
of regulated Class I gene products as detected by DEEP SEQ mass spectrometry with (f)
relative gene expression as measured by microarray and (g) relative protein translation as
measured by RNA-seq ribosomal profiling.
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Table 1
mESC proteins whose expression level increases or decreases in response to LIF
withdrawal (-LIF, 48hr)
upregulated downregulated
Def8 Bpgm Pygl
Dnmt3a Calb2 Rexo1
Dnmt3b Cd9 Rnf10
Dym Elovl6 Rps11
Eif1 Esrrb S100a6
Esyt2 Gjb3 Slc15a1
Grhl2 Hacl1 Slc35b2
Lef1 Jagn1 Snx22
Limd2 Klf4 Stard10
Lphn1 Klf5 Tbx3
Otx2 Mest Tcfcp2l1
Pld2 Padi2 Tekt3
Podxl Paf Tet3
Pou3f1 Pramef12 Ubxn1
Rplp0 Ptrf Vim
Soat1 Pvrl1 Zc3hav1
Trap1a
Zic2
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